Brazilian clinical trial of uniform multidrug therapy for leprosy patients : the correlation between clinical disease types and adverse effects
Uloženo v:
| Hlavní autor: | |
|---|---|
| Datum vydání: | 2012 |
| Další autoři: | , , , , , |
| Médium: | Article |
| Jazyk: | eng |
| Zdroj: | Repositório Institucional da UnB |
| Download full: | http://repositorio.unb.br/handle/10482/28309 https://dx.doi.org/10.1590/S0074-02762012000900013 |
Shrnutí: | This study sought to verify the correlation between leprosy types and the adverse effects of treatment drugs. This quantitative, prospective, nested study was developed at the Dona Libânia Dermatology Centre in Fortaleza, Brazil. Data were collected from November 2007-November 2008. During this period, 818 leprosy patients were diagnosed and began treatment. Forty patients with tuberculoid leprosy (TT) were selected. Twenty patients followed a standard therapy of dapsone and rifampicin and 20 were administered dapsone, rifampicin and clofazimine (U-MDT). Twenty patients with borderline lepromatous (BL) and lepromatous leprosy (LL) were also selected and treated with U-MDT. All of the subjects received six doses. With the exception of haemolytic anaemia, there was a low incidence of adverse effects in all the groups. We did not observe any differences in the incidence of haemolytic anaemia or other side effects across groups of patients with TT, BL or LL treated with U-MDT. |
Podobné jednotky: Brazilian clinical trial of uniform multidrug therapy for leprosy patients : the correlation between clinical disease types and adverse effects
- Clinical trial for uniform multidrug therapy for leprosy patients in Brazil (U-MDT/CT-BR): adverse effects approach
- A clinical trial for uniform multidrug therapy for leprosy patients in Brazil : rationale and design
- Effectiveness and safety of multidrug therapy containing clofazimine for paucibacillary leprosy and clarithromycin for rifampicin-resistant leprosy: a systematic review and meta-analysis
- The influence of leprosy-related clinical and epidemiological variables in the occurrence and severity of COVID-19 : a prospective realworld cohort study
- A randomized, open-label clinical trial comparing the long-term effects of miltefosine and meglumine antimoniate for mucosal leishmaniasis
- Trends of main indicators of leprosy in Brazilian municipalities with high risk of leprosy transmission, 2001–2012
